Tag: regdanvimab
Celltrion’s Monoclonal Antibody Treatment regdanvimab, Approved by the European Commission for the Treatment of COVID-19
Healthcare News
0
0
0
17 Nov, 08:22 AM
Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from MFDS
Healthcare News
0
0
0
20 Sep, 08:04 AM
Celltrion announces positive top-line results from global Phase III trial of regdanvimab (CT-P59), an anti-COVID-19 monoclonal antibody treatment
Healthcare News
0
0
0
22 Jun, 10:49 AM
